Filter
6536
Filtered Results: 6536
Text search:
World
Health
Organization
WHO,
et
al.
Featured
Recommendations
559
New Publications
1358
Language
Document type
No document type
3375
Studies & Reports
1388
Guidelines
883
Manuals
323
Strategic & Response Plan
187
Fact sheets
177
Training Material
115
Situation Updates
30
Resource Platforms
21
Infographics
17
Brochures
12
Online Courses
7
App
1
Countries / Regions
Global
283
India
161
Kenya
154
South Africa
145
Latin America and the Carribbean
136
Western and Central Europe
134
Ethiopia
113
Africa
109
Sierra Leone
99
Russia
97
Nigeria
96
Malawi
89
Uganda
82
Nepal
82
Zambia
81
Liberia
80
Ukraine
79
Syria
77
Bangladesh
73
Tanzania
68
Myanmar / Burma
66
Ghana
64
Eastern Europe
61
Brazil
56
Middle East and North Africa
55
Rwanda
49
Mozambique
48
Congo, Democratic Republic of
45
South–East Asia Region
45
Philippines
42
West and Central Africa
40
Senegal
39
Asia
39
Haiti
36
Germany
35
Yemen
35
Burkina Faso
34
Guinea
33
Namibia
33
Colombia
33
East and Southern Africa
33
Zimbabwe
32
Indonesia
32
Eastern Europe and Central Asia
32
South Sudan
28
Cambodia
27
Lesotho
26
Cameroon
24
Venezuela
23
Botswana
20
Pakistan
19
Sudan
19
Benin
19
Angola
19
Paraguay
16
Mali
14
Lebanon
14
China
14
Argentina
14
Western Pacific Region
14
Somalia
13
Jordan
13
Thailand
13
Peru
13
Guinea-Bissau
12
Chile
12
Tajikistan
12
Vietnam
11
Afghanistan
10
Eswatini/ Swaziland
10
Madagascar
10
Côte d’Ivoire / Ivory Coast
9
Niger
9
Chad
9
Ecuador
9
Mexico
9
Sri Lanka
9
Albania
9
Southern Africa
9
Spain
9
USA
8
Iraq
8
Central African Republic
8
Saudi Arabia
7
Libya
7
Kyrgyzstan
7
Georgia
7
Egypt
6
Guatemala
6
Laos
6
North America
6
Honduras
5
Palestine
5
Moldova
5
Iran
5
Kazakhstan
5
Tunisia
5
Belarus
5
Morocco
4
Turkey
4
El Salvador
4
Bolivia
4
Armenia
4
France
4
Portugal
4
Papua New Guinea
3
North Macedonia
3
Burundi
3
Nicaragua
3
Italy
3
Congo-Brazzaville
3
Canada
3
Timor Leste/ East Timor
3
Qatar
3
Estonia
3
Romania
3
Uruguay
3
United Kingdom
3
Togo
2
Malaysia
2
Greece
2
Fiji
2
Djibouti
2
Gabon
2
Turkmenistan
2
Jamaica
2
Japan
2
Denmark
2
Israel
2
Bosnia and Herzegovina
2
Mauritania
1
Ireland
1
Singapore
1
Dominican Republic
1
Switzerland
1
Hungary
1
Croatia
1
Cuba
1
Bhutan
1
Poland
1
North Korea
1
Mongolia
1
Bulgaria
1
Lithuania
1
Slovakia
1
Belgium
1
Mauritius
1
Algeria
1
Morocco
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2014
Clinical Guidelines
580
Public Health
392
Women & Child Health
364
Key Resources
290
Capacity Building
98
Pharmacy & Technologies
64
Toolboxes
COVID-19
684
Mental Health
623
HIV
619
TB
432
Planetary Health
335
Disability
253
NTDs
202
Caregiver
195
AMR
194
Rapid Response
162
Ebola
146
NCDs
142
Conflict
133
Global Health Education
129
Refugee
102
Pharmacy
89
Health Financing Toolbox
77
Natural Hazards
59
Zika
51
Polio
31
Specific Hazards
29
Cholera
28
Social Ethics
25
Health Financing
2
South Sudan
1
Typhoon
1
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region...
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
People affected by impairments and disabilities associated with TB are even more likely to belong to marginalized segments of society and are more likely to have their human rights unprotected. The challenges faced by people affected by TB include the consequences of impairment and disability associ...
This technical report has been developed within the framework of the WHO Global Initiative for
Childhood Cancer. Its goal is to improve the situation of children and adolescents with cancer worldwide,
giving them the best chances of survival, livi...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providin...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at ....
It addresses the use of Diphtheria Antitoxin (DAT) in the treatment of diphtheria. There is a worldwide shortage of DAT and evidence based recommendations on the use of DAT were requested by many Member States.
The guidance also includes new recommendations on antibiotics. In patients with suspected or confirmed diphtheria, WHO recommends using macrolide antibiotics (azithromycin, erythromycin) rather than penicillin antibiotics.
This clinical practice guideline has been rapidly developed recognizing the global increase in diphtheria outbreaks. Outbreaks of diphtheria in Nigeria, Guinea and neighbouring countries in 2023 have highlighted the urgent need for evidence-based clinical practice guidelines for the treatment of diphtheria. Given the sporadic nature of outbreaks, many clinicians in the affected regions have never managed acute diphtheria and its related complications. Diphtheria remains a neglected disease and vaccination is the top priority. At the same time, for patients with diphtheria, access to antibiotics, DAT and supportive care can be lifesaving.
Evidence-based psychological interventions are an important part of health, social, protection and education services and can help increase access to effective mental health treatments and progressi...
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public ... problem, one of four priority noncommunicable diseases (NCDs) targeted for action by world leaders. Both the number of cases and the prevalence of diabetes have been steadily increasing over the past few decades.
Terminology used to describe the transmission of pathogens through the air varies across scientific disciplines, organizations and the general public. While this has been the case for decades, during the coronavirus disease (COVID-19) pandemic, the ...
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is athe...
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory diseases – along with mental health, cause nearly three quarters of deaths in the .... Their drivers are social, environmental, commercial and genetic, and their presence is global. Every year 17 million people under the age of 70 die of NCDs, and 86% of them live in low- and middle-income countries (LMICs).
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory diseases – along with mental health, cause nearly three quarters of deaths in the .... Their drivers are social, environmental, commercial and genetic, and their presence is global. Every year 17 million people under the age of 70 die of NCDs, and 86% of them live in low- and middle-income countries (LMICs).
This document highlights landmarks and key milestones in the development and implementation of the global agenda for noncommunicable diseases (NCDs) over the last two decades. It summarizes where the world was in 2000, where it is in 2022, and where...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patte...
The Implementation toolkit for accessible telehealth services provides practical guidance to support governments, industry partners, health service providers and civil society groups in the use and implementation of the ...-ITU Global standard for accessibility of telehealth services. The toolkit is the result of a collaboration between the World Health Organization and the International Telecommunication Union, and was developed in response to the growing challenges that persons with disabilities and other marginalized populations experience when accessing and using telehealth platforms around the world.
Childhood Respiratory Diseases & the Environment learning objectives
•To understand how the respiratory tract is affected by the environment
•To describe respiratory diseases linked to the environment
•To list one population-level intervention and one personal-level intervention for d...
